Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials Nicolás Mendoza, Laura Pérez, Tommaso Simoncini, Alessandro Genazzani Reproductive BioMedicine Online Volume 35, Issue 5, Pages 529-535 (November 2017) DOI: 10.1016/j.rbmo.2017.07.005 Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Included studies. Reproductive BioMedicine Online 2017 35, 529-535DOI: (10.1016/j.rbmo.2017.07.005) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions
Figure 2 Comparison: myo-inositol plus folic acid versus folic acid alone. Outcome: oocyte quality (metaphase II oocytes). Reproductive BioMedicine Online 2017 35, 529-535DOI: (10.1016/j.rbmo.2017.07.005) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions
Figure 3 Comparison: myo-inositol plus folic acid versus folic acid alone. Outcome: embryo quality (grade I embryos). Reproductive BioMedicine Online 2017 35, 529-535DOI: (10.1016/j.rbmo.2017.07.005) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions
Figure 4 Comparison: myo-inositol plus folic acid versus folic acid alone. Outcome: clinical pregnancy rates. Reproductive BioMedicine Online 2017 35, 529-535DOI: (10.1016/j.rbmo.2017.07.005) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions
Figure 5 Comparison: myo-inositol plus folic acid versus folic acid alone. Outcome: total number of oocytes retrieved. Reproductive BioMedicine Online 2017 35, 529-535DOI: (10.1016/j.rbmo.2017.07.005) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions